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Summary. The interaction of the highly purified basic protein " antigen ", calf
thymus histone F2A1 fraction, with peripheral lymphocytes isolated from patients
with cancer and from normal subjects has been studied. Analysis, by SDS poly-
acrylamide gel electrophoresis of the basic protein remaining in the supernatant
fluid after interaction with low concentrations of lymphocytes from patients showed
the presence of a component(s) of molecular weight smaller than the original his-
tone F2Al fraction. Similar experiments using lymphocytes derived from normal
subjects indicated that this component(s) is absent, or at least is present in only
small amounts. This difference could be partially abolished by using high con-
centrations of cell preparations. It is suggested that the observed difference is due
at least in part, to differences in protease activity between the two preparations.
The possible significance of these findings in relation to the macrophage electro-
phoretic mobility test for cancer is discussed.
INTRODUCTION
IN RECENT YEARS much interest has
been focused on the interaction of a
variety of antigenic materials with peri-
pheral lymphocytes isolated from patients
with cancer. For instance, the in vitro
interaction of lymphocytes with glyco-
proteins from plant tissue (Yoffey and
Courtice, 1970) and extracts from nmicro-
organisms (Turk, 1972) has been utilized
to assess the immunological status of
patients with neoplasias of the reticulo-
endothelial and lymphoid system (Harris
and Sinkovics. 1970) and the immune
response of patients with a variety of
malignancies during treatment with anti-
cancer drugs (Campbell et al., 1973) and
radiotherapy (Braeman and Deeley. 1973).
More recentlv, the in vitro interaction of
several structurallv related basic proteins
with lymphocytes isolated from patients
with neoplasia have been studied (Field
and Caspary. 1970; Pritchard et al.,
1973a) and form the basis of an immuno-
diagnostic test, the macrophage electro-
phoretic mobility (MEM) test for all
forms of cancer (Field. Caspary and
Smith, 1973).
As part of a general plan to compare
the in vitro interaction of protein antigens
with lymphocyte preparations isolated
from normal subjects and patients with
malignant disease, the present study
deals with some aspects of the interaction
of calf thymus histone F2A1 fraction.
This basic protein was chosen for two
reasons. Firstly, it can be prepared in
highly purified form. Secondly, it has
recently been shown that the polypeptide
has the ability to act as an " antigen
in the MEM test (Johns et al., 1973).
A preliminary report of part of the
present work has been published (Fish,
1973).
MATERIALS AND -METHODS
Ficol was obtained from Pharmacia Fine
Chemical Ltd, Sweden, and Triosil from
Vestric Ltd, Runcorn, Cheshire. Tissue cul-
ture medium (TC 199) was a product ofHUMAN PERIPHERAL LYMPHOCYTES AND CANCER
Gibco, Grant Island Biological Company,
California. Jenner's and Giemsa's stains,
acrylamide, N,N,N1,Nl tetramethylethylene-
diamine, ammonium persulphate, N,N'-
methylenebisacrylamide, mercaptoethanol,
urea, bromophenol blue, NaH2PO42H2O and
anhydrous Na HPO4 were obtained from
B.D.H. Chemicals Ltd, Poole. Sodium dode-
cyl sulphate (SDS), specially pure from
B.D.H. was recrystallized once from hot
water. Coomassie blue was a product of
Imperial Chemical Industries Ltd, England.
The proteins used as molecular weight
markers for SDS gel calibration were cyto-
chrome c (horse heart) and y-globulin
(bovine) from Koch-Light Ltd, England;
pepsin (hog stomach) from Sigma Chemicals
Co. Ltd, England; albumin (bovine plasma)
from Armour Pharmaceuticals Co. Ltd,
England; trypsin (beef pancreas) and myo-
globin (horse heart) from B.D.H.
The basic protein used in the present
study was an arginine rich polypeptide
fraction F2A1 isolated from calf thymus
histone. Unlabelled and 1251-labelled poly-
peptide (approximately 100 ,uCi/mg) were
prepared by, and obtained as a generous
gift from Dr E. W. Johns, Chester Beatty
Institute, London. Encephalitogenic factor
(EF) and tumour antigen (basic protein
extract derived from a patient with car-
cinoma of the cervix) were prepared by
the method of Caspary and Field (1965
1971).
Preparation of lymphocytes.-Venous
blood (10-20 ml) wNas collected from patients
with clinically diagnosed cancer who had
not undergone any form of treatment, and
from healthy hospital workers. The blood
samples w-ere defibrinated and lymphocytes
wvere prepared by the Ficol-Triosil technique
used for the MEM test for cancer (Pritchard
et at., 1973b). After washing the cell pre-
parations 3 times with TC 199, the pellets
were resuspended in the same media. Ali-
quots of the cell suspensions wNere taken for
histological examination and lymphocyte
counting, using the Jenner-Giemsa staining
procedure.
Lymphocyte incubation studies.-A sample
of an appropriate diluted cell suspension
(500 1u) in TC 199 was incubated wAith
60 Mg of radioactively labelled F2A1 fraction
for 90 min at room temperature. The
suspension was then centrifuged at 1500 g
for 10 min using an M.S.E. bench centrifuge
with a swinging bucket rotor; the supernatant
fluid was carefully removed and the pellet
discarded.
Preparation of samples for SDS electro-
phoresis.-The protein samples and super-
natant fluids were incubated at 37°C for
2 h in 10 mmol/l sodium phosphate buffer,
pH 7 0 containing SDS at a final concen-
tration of 0.500. The samples (50 ,ul) were
then added to 100 ,ul aliquots of a tracking
dye mixture (50 ytl 0.0500 bromophenol
blue, 500 1I 10 mmol/l sodium phosphate
buffer pH 7-0 containing 0500 SDS and 10
drops of glycerol); 50 Iul or less of this
protein mixture was applied to polyacry-
lamide gels.
Electrophoretic conditions.-Electrophore-
sis was performed essentially by the method
of Weber and Osborne (1969). Polyacryl-
amide gels (5 x 75 mm) of 10% acrylamide
solution in sodium phosphate buffer (8-8 g
NaH2PO4; 20-5 g Na2HPO4 per litre, pH
6-9) containing 0-2%/ SDS, were used for
all experiments. An analytical disc gel
electrophoresis apparatus with a constant
current power supply (Shandon Scientific
Co. Ltd, London) was used for all fractiona-
tions. Reservoir buffers consisted of gel
buffer diluted 1: 1 with water. Electro-
phoresis was performed for 21-3 h at a
constant current of 8 mA per gel with the
positive electrode in the lower chamber.
Staining and de-staining of gels. After
electrophoresis, the gels wrere removed from
the glass tubes and the total gel length and
the migration distance of the tracking dye
noted. The gels were then stained for
protein with coomassie brilliant blue by the
method described by Fairbanks, Steck and
Wallach (1971). The relative migration of
the protein standards and the histone
fraction were calculated relative to the
tracking dye.
Measurement of gel radioactivity.-After
electrophoresis, gels containing 1251 com-
ponents were immediately cut laterally into
segments by means of a razor blade and a
metal stop w-ith a 2 mm spacer. This
simple procedure allowed reasonably uniform
sections of approximately 2 mm width to be
obtained. The segments wvere placed in
plastic vials and the radioactivity in the
fractions measured twice for 100 s in a well
gamma counter. In some experiments radio-
activity was monitored twvice for 1000 s in
an automatic gamma counter.
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FIG. 1.-Separation of (a) calfthymus histone
F2A1 fraction. (b) Partially purified ence-
phalitogenic factor. (c) Basic protein ex-
tract from carcinoma of cervix, by SDS
polyacrylamide gelelectrophoresis. Migra
tion is from negative to positive.
RESULTS
Electrophoretic fractionation of histone
fraction F2A1
Figure 1(a) shows the behaviour of
fraction F2A1 on polyacrylamide gel
electrophoresis in sodium dodecyl sul-
phate after staining the gels with coo-
massie brilliant blue. One main com-
ponent was present that had a relative
migration slightly less than that of
cytochrome c. A slower moving minor
component was also visible immediately
after de-staining but was found to dis-
appear when the gels were stored in 10%
acetic acid for any length of time. The
electrophoretic pattern was unaltered by
reducing the basic protein with 1%
mereaptoethanol, by the addition of urea
(3 mol/l final concentration), or by pre-
paring the protein in tissue culture
medium 199. Variation in the concen-
tration of SDS (2 %, 1 %0 0-1 %) also gave
a similar electrophoretic pattern.
In order to demonstrate that the
method was capable of separating more
complex mixtures of basic proteins, a
preparation of normal human brain en-
cephalitogenic factor (EF) and tumour
antigen were subjected to SDS electro-
phoresis and the results are shown in
Fig. 1(b)(c) respectively. The human
brain extract was shown to have a main
component of molecular weight approxi-
mately 20,000 daltons but a multiplicity
of other components was also visible.
The tumour extract was extremely hetero-
geneous and consisted of components with
molecular weights ranging from less than
10,000 to greater than 100,000 daltons.
Electrophoretic fractionation of 1251-histone
F2A1 after interaction with lynwphocytes
The radioactive distribution of 1251-
histone F2A1 fraction after electrophoresis
in sodium dodecyl sulphate (Fig. 2a) was
similar to the electrophoretic pattern
obtained when F2A1 fraction is stained
with coomassie brilliant blue (Fig. 1).
The radioactive profiles of the super
natant fluids after interaction of 1251-
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FIG. 2.-SDS electrophoresis of radioactive components obtained from supernatant fluid after
interaction of 1251-histone F2A1 fraction with 1 x 106 lymphocytes derived from normal subjects.
Migration is from negative to positive (a) original 1251-histone F2A1 (b, c, d, e, f) normal subjects
who gave a negative result in the MEM test.
histone F2A1 fraction with low concen- results indicate that there were significant
trations of lymphocytes derived from differences in the electrophoretic pattern
5 healthy hospital workers and 5 patients of supernatants derived from the 2
with a clinically diagnosed cancer are lymphocyte populations. Using lympho-
shown in Fig. 2 and 3 respectively. The cyte preparations from patients with226 R. G. FISH, J. A. V. PRITCHARD AND T. J. DEELEY
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FIG. 3. SDS electrophoresis of radioactive components obtained from supernatant fluid after
interaction of 1251-histone F2AL fraction with 1 x 106 lymphocytes derived from patients. Migra-
tion is from negative to positive. (a) Original 125I-histone F2AI, (b) Ca cervix, (c) Ca breast, (d)
Ca cervix, (e) Ca breast, (f) Ca vulva. All patients gave a positive result in the MEM test.
malignant disease, a new radioactive The radioactive profiles of the super-
peak appeared ofmolecular weight smaller natant fluid after interaction of 125I_
than the original histone F2Al fraction. histone F2A1 fraction with 2 concentra-
Sinmilar experiments showed that this low tions of lymphocytes derived from a
molecular weight radioactive material normal subject and a patient with cancer
was absent, or at least was present only are shown in Fig. 4, and indicated that the
in small amounts, when lymphocytes appearance of the low molecular weight
were derived from normal subjects. radioactive peak on the electrophoreticHUMAN PERIPHERAL LYMPHOCYTES AND CANCER
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FiG. 4. SDS electrophoresis of radioactive components obtained from supernatant fluid after
interaction of 1251-histone F2AL fraction with 2 concentrations of lymphocytes derived from
a normal subject and a patient with a carcinoma of the cervix (a, c) 2 x 106 cells (b, d) 6 x 106
cells.
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gels was dependent upon the number of
cells from both sources.
Morphology of the lymphocyte preparations
A histological comparison between cell
preparations obtained by the Ficol-Triosil
technique using peripheral blood from a
normal subject and a patient with cancer
is shown in Fig. 5. Although this tech-
nique yields cell preparations from both
sources that contain mainly lymphocytes,
it would seem that a number of these
cells are damaged and the degree of
contamination of the preparation with
other blood components is greater in
patients with cancer than in normal
controls.
DISCUSSION
The major finding of this work is
that under specified conditions there is
a significant difference in the electro-
phoretic profile of 1251-histone F2A1 frac-
tion after interaction with peripheral
lymphocyte preparations derived from
normal subjects and from patients with
clinically diagnosed cancer. It has been
shown that a new radioactive peak.
migrating faster than the intact histone
F2A1 fraction, appears on the electro-
phoretograms after interaction of the
polypeptide with lymphocyte preparations
from cancer patients. Similar studies per-
formed with the same number of lympho-
cytes from normal subjects showed that
this radioactive peak was absent, or at
least present in only trace amounts,
under the conditions of the experiment.
The possibility was considered as to
whether the appearance of the low
molecular weight radioactive peak was
due to reversible aggregation dissocia-R. G. FISH, J. A. V. PRITCHARD AND T. J. DEELEY
FiG. 5. Histological examination of purified lymphocyte preparations from (i) normal subject,
(ii) patient with cancer; note cell damage and increased numbers of contaminating cells
with tbis preparation (A) lymphocyte, (B) polymorphonuclear leucocyte, (C) unidentified cell.
Magniification x 250.
tion of the histone F2A1 fraction. Al-
though the electrophoresis process itself
is relatively free from artefacts. these may
be produced in preparing the histone
F2A1 forelectrophoresis. Electrophoretic
studies in the presence of sodium dodecyl
sulphate show that F2A1 fraction consists
of one major component. This pattern
of electrophoresis is unchanged when the
polypeptide is prepared in TC 199.
reduced with mereaptoethanol or by
denaturation with urea. Similarly. a
five-fold reduction in the concentration
of SDS gives an identical pattern of
electrophoresis. These observations.
coupled with dependence upon cell con-
centration (Fig. 4). suggest that the
appearance of low molecular weight com-
ponents on the gels may be due to pro-
teolytic degradation of the original F2A1
fraction.
Although both types of isolated cell
preparations consist mainly of lympho-
cytes, there would seem to be a greater
degree of contamination with other blood
components, such as red cells and poly-
morphonuclear leucocytes, in the peri-
pheral blood from patients with cancer
(Fig. 5). No detailed comparative study
has vet been made of the recovery and
puritv of the isolated lymphocyte pre-
parations from both sources. but work is
now in progress to resolve this problem.
Although lysosomal enzymes have been
detected in human lymphocvtes (Cichocki,
Astaldi and Lisiewicz. 1972). and it has
been suggested that proteases are present
in the erythrocyte membrane (Morrison
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and Neurathy, 1953; Moore et al., 1970),
it would seem more reasonable that the
polymorphonuclear leucocytes are a likely
source of proteases. Neutral proteases,
capable of degrading orcein impregnated
elastin and N-benzyloxycarbonyl-L-alan-
ine p-nitrophenol ester (Janoff and Sche-
rer, 1968; Janoff, 1969) collagen (Lazarus
et al., 1968), calf thymus histone and
haemoglobin (Weissman, Zurier and Hoff-
stein, 1970), have been described in
human polymorphonuclear leucocytes.
The preliminary observations that the
histone F2A1 fraction may be prefer-
entially degraded by low concentrations
of lymphocyte preparations from patients
with cancer deserves special comment.
It should be noted that the conditions
used in the present study for the inter-
action of the basic protein with lympho-
cyte preparations are identical to those
used for the MEM test for cancer (Prit-
chard et al., 1973a). Since it is now
known that the histone F2A1 fraction is
capable of acting as an " antigen " in this
test, it is not unreasonable to suggest that
other basic proteins such as encephalito-
genic factor and tumour antigen may also
be partially degraded to peptide frag-
ments by proteolytic action of isolated
cell preparations derived from patients
with cancer. It is conceivable that one
or more of these peptide fragments could
act as a macrophage slowing factor(s).
Further progress must wait the isolation
of these basic proteins in a pure state.
The present study indicates that there
are differences in proteolytic activity
toward the basic polypeptide, histone
F2A1 fraction, between lymphocyte pre-
parations isolated from normal indivi-
duals, and patients with malignant dis-
ease. Whether such differences occur
with other proteins, or with lymphocyte
preparations from patients with non-
malignant diseases, is the subject of
further investigation.
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